(Total Views: 189)
Posted On: 01/30/2017 12:00:34 PM
Post# of 25900

$OBMP Latest Clinical Data from OncBioMune Supports Safety and Therapeutic Profile of ProscaVax for Prostate Cancer for Upcoming Phase 2 Clinical Trials
https://finance.yahoo.com/news/latest-clinica...59215.html
https://finance.yahoo.com/news/latest-clinica...59215.html

